INFI logo

Infinity Pharmaceuticals (INFI) CAPEX

INFI Annual CAPEX

$17.00 K
+$6000.00+54.55%

31 December 2022

1-Year Change

+54.55%
INFI annual capital expenditures is up +54.55% year-on-year

3-Year Change

-99.27%
INFI annual capital expenditures is down -99.27% over the past 3 years

All-time High

$19.70 M
INFI annual capital expenditures is currently -99.91% below its historical high of $19.70 million
Annual FCF-$42.45 M
INFI annual free cash flow is -$42.45 million
Annual CFO-$42.43 M
INFI annual cash flow from operations is -$42.43 million
Annual CFI-$55.00 K
INFI annual cash flow from investing activities is -$55.00 thousand
Annual CFF$73.00 K
INFI annual cash flow from financing activities is $73.00 thousand

INFI CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INFI Quarterly CAPEX

N/A

30 June 2023

All-time High

$17.11 M
INFI quarterly capital expenditures is currently at an all-time high
Quarterly FCF-$8.01 M
INFI quarterly free cash flow is -$8.01 million
Quarterly CFO-$8.01 M
INFI quarterly cash flow from operations is -$8.01 million
Quarterly CFI$0.00
INFI quarterly cash flow from investing activities is $0.00
Quarterly CFF$16.00 K
INFI quarterly cash flow from financing activities is $16.00 thousand

INFI Quarterly CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INFI TTM CAPEX

N/A

30 June 2023

All-time High

$19.78 M
INFI TTM capital expenditures is currently at an all-time high
TTM FCF-$38.88 M
INFI TTM free cash flow is -$38.88 million
TTM CFO-$38.88 M
INFI TTM cash flow from operations is -$38.88 million
TTM CFI$10.73 M
INFI TTM cash flow from investing activities is $10.73 million
TTM CFF$61.00 K
INFI TTM cash flow from financing activities is $61.00 thousand

INFI TTM CAPEX Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

INFI CAPEX Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+54.5%--
3 y3 years-99.3%--
5 y5 years-60.5%--

INFI CAPEX High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-99.9%

Infinity Pharmaceuticals CAPEX History

DateAnnualQuarterlyTTM
Dec 2022
$17.00 K(+54.5%)
$0.00(0.0%)
$17.00 K(0.0%)
Sept 2022
-
$0.00(0.0%)
$17.00 K(-39.3%)
June 2022
-
$0.00(-100.0%)
$28.00 K(0.0%)
Mar 2022
-
$17.00 K(>+9900.0%)
$28.00 K(+154.5%)
Dec 2021
$11.00 K(-74.4%)
$0.00(-100.0%)
$11.00 K(+10.0%)
Sept 2021
-
$11.00 K(-1200.0%)
$10.00 K(-76.7%)
Dec 2020
$43.00 K(-98.2%)
-$1000.00(<-9900.0%)
$43.00 K(-94.7%)
Sept 2020
-
$0.00(-100.0%)
$811.00 K(-62.2%)
June 2020
-
$26.00 K(+44.4%)
$2.15 M(-7.1%)
Mar 2020
-
$18.00 K(-97.7%)
$2.31 M(-0.6%)
Dec 2019
$2.33 M(+5311.6%)
$767.00 K(-42.6%)
$2.33 M(+49.2%)
Sept 2019
-
$1.34 M(+599.5%)
$1.56 M(+596.4%)
June 2019
-
$191.00 K(+478.8%)
$224.00 K(+578.8%)
Mar 2019
-
$33.00 K(+94.1%)
$33.00 K(-23.3%)
Dec 2017
$43.00 K(-93.5%)
$17.00 K(-34.6%)
$43.00 K(+65.4%)
Sept 2017
-
$26.00 K(>+9900.0%)
$26.00 K(-96.1%)
Dec 2016
$661.00 K(-89.7%)
$0.00(-100.0%)
$661.00 K(-60.4%)
Sept 2016
-
$23.00 K(-93.8%)
$1.67 M(-46.0%)
June 2016
-
$368.00 K(+36.3%)
$3.10 M(-44.6%)
Mar 2016
-
$270.00 K(-73.3%)
$5.58 M(-13.1%)
Dec 2015
$6.43 M(+371.8%)
$1.01 M(-30.2%)
$6.43 M(+0.2%)
Sept 2015
-
$1.45 M(-49.4%)
$6.41 M(+26.8%)
June 2015
-
$2.86 M(+156.9%)
$5.06 M(+120.2%)
Mar 2015
-
$1.11 M(+11.4%)
$2.30 M(+68.7%)
Dec 2014
$1.36 M(-22.3%)
$998.00 K(+973.1%)
$1.36 M(+76.4%)
Sept 2014
-
$93.00 K(-2.1%)
$772.00 K(-26.8%)
June 2014
-
$95.00 K(-46.0%)
$1.05 M(-35.8%)
Mar 2014
-
$176.00 K(-56.9%)
$1.64 M(-6.3%)
Dec 2013
$1.75 M(+34.8%)
$408.00 K(+8.8%)
$1.75 M(-11.4%)
Sept 2013
-
$375.00 K(-45.2%)
$1.98 M(+2.0%)
June 2013
-
$684.00 K(+138.3%)
$1.94 M(+43.6%)
Mar 2013
-
$287.00 K(-54.7%)
$1.35 M(+3.9%)
Dec 2012
$1.30 M(-15.6%)
$634.00 K(+88.7%)
$1.30 M(-6.2%)
Sept 2012
-
$336.00 K(+253.7%)
$1.39 M(+12.1%)
June 2012
-
$95.00 K(-59.7%)
$1.24 M(-14.5%)
Mar 2012
-
$236.00 K(-67.2%)
$1.45 M(-6.2%)
Dec 2011
$1.54 M(-20.9%)
$720.00 K(+287.1%)
$1.54 M(+22.5%)
Sept 2011
-
$186.00 K(-39.0%)
$1.26 M(-24.0%)
June 2011
-
$305.00 K(-7.9%)
$1.66 M(+5.0%)
Mar 2011
-
$331.00 K(-24.2%)
$1.58 M(-19.0%)
Dec 2010
$1.95 M
$436.60 K(-25.3%)
$1.95 M(-10.8%)
Sept 2010
-
$584.40 K(+158.5%)
$2.19 M(+12.2%)
DateAnnualQuarterlyTTM
June 2010
-
$226.10 K(-67.8%)
$1.95 M(-14.9%)
Mar 2010
-
$702.00 K(+4.4%)
$2.29 M(-9.5%)
Dec 2009
$2.53 M(+81.5%)
$672.60 K(+93.9%)
$2.53 M(-4.5%)
Sept 2009
-
$346.80 K(-38.7%)
$2.65 M(+10.6%)
June 2009
-
$565.80 K(-40.0%)
$2.39 M(+5.1%)
Mar 2009
-
$942.40 K(+19.2%)
$2.28 M(+63.4%)
Dec 2008
$1.39 M(-42.1%)
$790.80 K(+750.3%)
$1.39 M(+108.6%)
Sept 2008
-
$93.00 K(-79.3%)
$667.40 K(-26.2%)
June 2008
-
$449.60 K(+662.0%)
$904.40 K(-44.4%)
Mar 2008
-
$59.00 K(-10.3%)
$1.63 M(-32.4%)
Dec 2007
$2.41 M(+154.1%)
$65.80 K(-80.1%)
$2.41 M(+0.2%)
Sept 2007
-
$330.00 K(-71.8%)
$2.40 M(-3.4%)
June 2007
-
$1.17 M(+39.6%)
$2.49 M(+42.8%)
Mar 2007
-
$838.80 K(+1259.5%)
$1.74 M(+83.9%)
Dec 2006
$946.60 K(-59.7%)
$61.70 K(-85.1%)
$946.60 K(-1.2%)
Sept 2006
-
$414.20 K(-2.8%)
$957.80 K(-66.0%)
June 2006
-
$426.00 K(+853.0%)
$2.82 M(+48.0%)
Mar 2006
-
$44.70 K(-38.7%)
$1.90 M(-18.9%)
Dec 2005
$2.35 M(-32.2%)
$72.90 K(-96.8%)
$2.35 M(-45.9%)
Sept 2005
-
$2.28 M(-565.8%)
$4.34 M(+77.4%)
June 2005
-
-$488.50 K(-200.0%)
$2.45 M(-30.6%)
Mar 2005
-
$488.50 K(-76.3%)
$3.52 M(+1.8%)
Dec 2004
$3.46 M(+59.4%)
$2.06 M(+439.7%)
$3.46 M(+60.3%)
Sept 2004
-
$382.30 K(-35.1%)
$2.16 M(-9.6%)
June 2004
-
$589.00 K(+38.0%)
$2.39 M(+21.5%)
Mar 2004
-
$426.70 K(-44.0%)
$1.97 M(-9.5%)
Dec 2003
$2.17 M(-19.9%)
$761.70 K(+24.5%)
$2.17 M(+1.9%)
Sept 2003
-
$611.60 K(+267.1%)
$2.13 M(+33.6%)
June 2003
-
$166.60 K(-73.6%)
$1.59 M(-29.3%)
Mar 2003
-
$632.00 K(-12.3%)
$2.26 M(-16.7%)
Dec 2002
$2.71 M(-86.2%)
$720.40 K(+847.9%)
$2.71 M(-85.8%)
Sept 2002
-
$76.00 K(-90.8%)
$19.10 M(-1.3%)
June 2002
-
$828.90 K(-23.6%)
$19.35 M(-2.2%)
Mar 2002
-
$1.08 M(-93.7%)
$19.78 M(+0.4%)
Dec 2001
$19.70 M(+204.5%)
$17.11 M(+5164.0%)
$19.70 M(+205.9%)
Sept 2001
-
$325.00 K(-74.3%)
$6.44 M(-3.3%)
June 2001
-
$1.27 M(+27.1%)
$6.66 M(+3.6%)
Mar 2001
-
$997.10 K(-74.1%)
$6.43 M(-0.6%)
Dec 2000
$6.47 M(+481.6%)
$3.85 M(+604.2%)
$6.47 M(+146.9%)
Sept 2000
-
$546.60 K(-47.2%)
$2.62 M(+26.4%)
June 2000
-
$1.03 M(-0.3%)
$2.07 M(+99.7%)
Mar 2000
-
$1.04 M
$1.04 M
Dec 1999
$1.11 M
-
-

FAQ

  • What is Infinity Pharmaceuticals annual capital expenditures?
  • What is the all time high annual CAPEX for Infinity Pharmaceuticals?
  • What is Infinity Pharmaceuticals annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for Infinity Pharmaceuticals?
  • What is the all time high TTM CAPEX for Infinity Pharmaceuticals?

What is Infinity Pharmaceuticals annual capital expenditures?

The current annual CAPEX of INFI is $17.00 K

What is the all time high annual CAPEX for Infinity Pharmaceuticals?

Infinity Pharmaceuticals all-time high annual capital expenditures is $19.70 M

What is Infinity Pharmaceuticals annual CAPEX year-on-year change?

Over the past year, INFI annual capital expenditures has changed by +$6000.00 (+54.55%)

What is the all time high quarterly CAPEX for Infinity Pharmaceuticals?

Infinity Pharmaceuticals all-time high quarterly capital expenditures is $17.11 M

What is the all time high TTM CAPEX for Infinity Pharmaceuticals?

Infinity Pharmaceuticals all-time high TTM capital expenditures is $19.78 M